Compugroup Medical SE (ETR:COP) has been given a €60.00 ($70.59) target price by Deutsche Bank AG in a report issued on Tuesday, August 1st. The brokerage presently has a “buy” rating on the stock.
Several other equities research analysts have also recently commented on the company. HSBC Holdings plc set a €60.00 ($70.59) target price on Compugroup Medical SE and gave the company a “buy” rating in a research note on Wednesday, July 5th. Baader Bank set a €52.00 ($61.18) price objective on Compugroup Medical SE and gave the stock a “buy” rating in a research note on Saturday, May 20th. Finally, Warburg Research set a €52.00 ($61.18) price objective on Compugroup Medical SE and gave the stock a “neutral” rating in a research note on Tuesday, June 20th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Compugroup Medical SE currently has an average rating of “Buy” and an average price target of €55.40 ($65.18).
Shares of Compugroup Medical SE (COP) opened at 50.001 on Tuesday. The stock has a 50 day moving average price of €49.71 and a 200 day moving average price of €45.20. Compugroup Medical SE has a one year low of €36.21 and a one year high of €52.80. The firm has a market cap of €2.49 billion and a price-to-earnings ratio of 54.646.
Compugroup Medical SE Company Profile
Compugroup Medical SE is a Germany-based software developer. The Company focuses on software solutions to the healthcare industry, including physicians, pharmacies, health insurances, laboratories, hospitals and rehabilitation and care facilities. Its activities are divided into three segments: Health Provider Services I, Health Provider Services II and Health Connectivity Services.
What are top analysts saying about Compugroup Medical SE? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Compugroup Medical SE and related companies.